Sands Capital Ventures, LLC
Q1 2025 13F Holdings
- Locationarlington, VA
- Num holdings
20
- Value ($000)
$408,897
- Date Filed05/14/2025
- Form type13F-HR
- CIK0001846444
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
KVYO KLAVIYO INC | COM SER A | 49845K101 | $104.20M | 26 % | 3,443,515 | ||
NU NU HLDGS LTD | ORD SHS CL A | G6683N103 | $73.36M | 18 % | 7,164,355 | ||
DASH DOORDASH INC | CL A | 25809K105 | $69.58M | 17 % | 380,704 | ||
BETA BIONICS INC | COM | 08659B102 | $37.99M | 9 % | 3,103,782 | ||
IKT INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | $23.98M | 6 % | 10,950,000 | ||
CPNG COUPANG INC | CL A | 22266T109 | $18.50M | 5 % | 843,476 | ||
MONDAY COM LTD | SHS | M7S64H106 | $12.14M | 3 % | 49,908 | ||
DDOG DATADOG INC | CL A COM | 23804L103 | $11.70M | 3 % | 117,930 | ||
IOT SAMSARA INC | COM CL A | 79589L106 | $9.71M | 2 % | 253,432 | ||
TARS TARSUS PHARMACEUTICALS INC | COM | 87650L103 | $8.73M | 2 % | 170,000 |
Rows Per Page
10
- 10
- 50
- 100